Bahig H, Ye RZ, Aubin F, Nguyen-Tan PF, et al. Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma. Int J Radiat Oncol Biol Phys 2026 Aug 12:S0360-3016(26)04138.
PMID: 42586218